E. Mazoyer

14 papers receiving 832 citations

Peers

E. Mazoyer
Comparison fields: 5 of 83
  • Emergency Medical Services 131
  • Neurology 247
  • Surgery 622
  • Internal Medicine 38
  • Oncology 244
Replace Patricio Rojas with:
Patricio Rojas Chile
Kon‐Siong G. Jie Netherlands
Chan Ho Kim South Korea
Kostas Sombolos Greece
Monika Raut United States
Carol A. Raviola United States
Katarzyna Madziarska Poland
Jari Petäjä Finland
Manfred Wallner Austria
Ana I. Casanegra United States
E. Mazoyer relative to Patricio Rojas Chile Patricio Rojas's profile →
Citations per field
00.5×3.6×
Patricio Rojas · 1×
Citations per year

Countries citing papers authored by E. Mazoyer

Since Specialization
Citations

This map shows the geographic impact of E. Mazoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mazoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mazoyer more than expected).

Fields of papers citing papers by E. Mazoyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Mazoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mazoyer. The network helps show where E. Mazoyer may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Mazoyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Mazoyer Line = papers co-authored together E. Mazoyer links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 1997306
2 1997158
3 2002139
4 2002133
5
Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study.
200655
6 199424
7 199522
8 199421
9 199918
10 19944
11 20053
12
[The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].
19982
13
[Antiphospholipid antibodies: cause of thrombosis or an epiphenomenon?].
19952
14
Use of the caseino-glycopeptide k, particularly from cow milk, in the manufacture of a composition, and particularly of a medicine, for use in the prevention and treatment of thrombosis.
19901
15 20050

About E. Mazoyer

E. Mazoyer is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Neurology, Hematology and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 888 indexed citations. Recurring topics across this work include Blood properties and coagulation (4 papers), Vascular Malformations Diagnosis and Treatment (3 papers), Vascular Malformations and Hemangiomas (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Central Venous Catheters and Hemodialysis (2 papers), Platelet Disorders and Treatments (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Emergency Medical Services (131 citations), Neurology (247 citations), Surgery (622 citations), Internal Medicine (38 citations) and Oncology (244 citations). E. Mazoyer has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Ludovic Drouet, O Enjolras, Claude Laurian, Alain Taı̈eb, J.‐F. Stalder, Ilona J. Frieden, Jean-Paul Escande, Paul N.M.A. Rieu, Michel Wassef and Denis Herbreteau. Their work appears in journals such as Thrombosis Research, Journal of the American Academy of Dermatology, The Journal of Pediatrics, British Journal of Haematology and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact